中华航海医学与高气压医学杂志
中華航海醫學與高氣壓醫學雜誌
중화항해의학여고기압의학잡지
Chinese Journal of Nautical Medicine and Hyperbaric Medicine
2015年
4期
255-257,278
,共4页
赵林%蒋怡佳%马文良%康南%苏庆军%王国忠%高春锦%杨晶
趙林%蔣怡佳%馬文良%康南%囌慶軍%王國忠%高春錦%楊晶
조림%장이가%마문량%강남%소경군%왕국충%고춘금%양정
急性脊髓损伤%高压氧%血浆HMGB1%血浆NF-κB
急性脊髓損傷%高壓氧%血漿HMGB1%血漿NF-κB
급성척수손상%고압양%혈장HMGB1%혈장NF-κB
Acute spinal cord injury%Hyperbaric oxygen%Plasma HMGB1%Plasma NF-κB
目的 探讨高压氧治疗对急性脊髓损伤患者血浆HMGB1/NF-κB表达的影响.方法 经患者知情同意,将82例急性脊髓损伤患者分为对照组(常规治疗)40例和治疗组(常规治疗+高压氧治疗)42例.在治疗前、治疗后第1、3、7、10、30天相同时间点,采用ELISA法检测患者血浆HMGB1/NF-κB水平,应用脊髓ASIA损伤分级评价总有效率.结果 对照组急性脊髓损伤患者血浆HMGBI水平升高,峰值出现在治疗后第3天.治疗组患者治疗后血浆HMGB1水平降低,与对照组比较,在治疗后第3、7、10、30天差异具有统计学意义(P<0.01),高压氧治疗后第30天血浆HMGB1水平依然高于损伤时的基线值.对照组血浆NF-κB水平升高,峰值出现在治疗后第1天.治疗组患者治疗后血浆NF-κB水平降低,与对照组比较,在治疗后第3、7天(P<0.05)、第10、30天(P<0.01)差异具有统计学意义(P<0.01),高压氧治疗后第30天血浆NF-κB水平明显低于损伤时的基线值.与对照组(70.0%)比较,高压氧治疗组总有效率为85.7%,差异有统计学意义(P<0.05).结论 高压氧可通过降低外周血HMGB1/NF-κB水平,减轻急性脊髓损伤患者继发性损伤中的炎症反应,促进患者神经功能修复.
目的 探討高壓氧治療對急性脊髓損傷患者血漿HMGB1/NF-κB錶達的影響.方法 經患者知情同意,將82例急性脊髓損傷患者分為對照組(常規治療)40例和治療組(常規治療+高壓氧治療)42例.在治療前、治療後第1、3、7、10、30天相同時間點,採用ELISA法檢測患者血漿HMGB1/NF-κB水平,應用脊髓ASIA損傷分級評價總有效率.結果 對照組急性脊髓損傷患者血漿HMGBI水平升高,峰值齣現在治療後第3天.治療組患者治療後血漿HMGB1水平降低,與對照組比較,在治療後第3、7、10、30天差異具有統計學意義(P<0.01),高壓氧治療後第30天血漿HMGB1水平依然高于損傷時的基線值.對照組血漿NF-κB水平升高,峰值齣現在治療後第1天.治療組患者治療後血漿NF-κB水平降低,與對照組比較,在治療後第3、7天(P<0.05)、第10、30天(P<0.01)差異具有統計學意義(P<0.01),高壓氧治療後第30天血漿NF-κB水平明顯低于損傷時的基線值.與對照組(70.0%)比較,高壓氧治療組總有效率為85.7%,差異有統計學意義(P<0.05).結論 高壓氧可通過降低外週血HMGB1/NF-κB水平,減輕急性脊髓損傷患者繼髮性損傷中的炎癥反應,促進患者神經功能脩複.
목적 탐토고압양치료대급성척수손상환자혈장HMGB1/NF-κB표체적영향.방법 경환자지정동의,장82례급성척수손상환자분위대조조(상규치료)40례화치료조(상규치료+고압양치료)42례.재치료전、치료후제1、3、7、10、30천상동시간점,채용ELISA법검측환자혈장HMGB1/NF-κB수평,응용척수ASIA손상분급평개총유효솔.결과 대조조급성척수손상환자혈장HMGBI수평승고,봉치출현재치료후제3천.치료조환자치료후혈장HMGB1수평강저,여대조조비교,재치료후제3、7、10、30천차이구유통계학의의(P<0.01),고압양치료후제30천혈장HMGB1수평의연고우손상시적기선치.대조조혈장NF-κB수평승고,봉치출현재치료후제1천.치료조환자치료후혈장NF-κB수평강저,여대조조비교,재치료후제3、7천(P<0.05)、제10、30천(P<0.01)차이구유통계학의의(P<0.01),고압양치료후제30천혈장NF-κB수평명현저우손상시적기선치.여대조조(70.0%)비교,고압양치료조총유효솔위85.7%,차이유통계학의의(P<0.05).결론 고압양가통과강저외주혈HMGB1/NF-κB수평,감경급성척수손상환자계발성손상중적염증반응,촉진환자신경공능수복.
Objective To investigate the effect of hyperbaric oxygen (HBO) on the expression level of plasma HMGB1/NF-κB in patients with acute spinal cord injury.Methods With the knowledge and consent of the patients,82 cases of acute spinal cord injury were divided into the control group (or the routine treatment group) (n =40) and the treatment group (or the routine treatment + HBO therapy group) (n =42).Plasma levels of HMGB1/NF-kappa B (kB) were detected by ELISA,both before treatment and at the same time points of day 3,7,10 and 30 after treatment.Total effective rate was evaluated by using ASIA scores of spinal cord injury.Results The plasma HMGB1 levels of the patients with acute spinal cord injury in the control group were elevated,and the peak value was at day 3 after treatment.The plasma HMGB1 levels of the patients in the HBO group were decreased after HBO treatment.Statistical differences in the plasma HMGB1 levels could be seen at day 3,7,10 and 30 after treatment,as compared with those of the control group (P < 0.01).However,the plasma HMGB1 level at day 30 following HBO therapy was still higher than that of the baseline at the time of injury.The plasma NF-kB levels for the patients of the control group were decreased,with the peak level at day 1 after treatment.As compared with those of the control group,the levels of plasma NF-kB for the patients of the HBO group were also decreased,and statistical significance could be noted in its levels at day 3,7 and 30 after treatment (P < 0.01).The level of NF-kB at day 30 after HBO was significantly lower than that of the baseline at the time of injury.Total effective rate for the HBO group was 85.7%,as compared with that of the control group (70.0%),and statistical significance could be noticed,when comparisons were made between them (P < 0.05).Conclusions HBO therapy could decrease inflammatory reaction of secondary injury by decreasing HMGB1/ NF-kappa B levels in peripheral blood,and promote recovery of neurological function in patients with acute spinal cord injury.